Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
In this study, it was aimed to investigate the survival rate and prognostic factors affecting survival in triple negative male breast cancer patients. Data were obtained from SEER (Surveillance Epidemiology and End Results). Triple-negative male breast cancer patients between 2010 and 2019 were incl...
Saved in:
Main Authors: | Ahmet Necati Sanli, Bilal Turan |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Turaz Bilim
2024-04-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | https://www.medicinescience.org/?mno=204664 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
by: Yi-Zi Zheng, et al.
Published: (2025-02-01) -
The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer
by: Jie Zhu, et al.
Published: (2025-02-01) -
Prognostic factors in hereditary breast cancer: A review
by: Ziske Maritska, et al.
Published: (2024-08-01) -
Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01) -
Harnessing artificial intelligence for predicting breast cancer recurrence: a systematic review of clinical and imaging data
by: Jaqueline Alvarenga Silveira, et al.
Published: (2025-02-01)